ProShare Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Sell |
|
|||||
|
2025
Q1 | $499K | Sell |
|
|||||
|
2024
Q4 | $1.05M | Buy |
|
|||||
|
2024
Q3 | $414K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $285K | Sell |
|
|||||
|
2023
Q1 | $440K | Sell |
|
|||||
|
2022
Q4 | $737K | Sell |
|
|||||
|
2022
Q3 | $778K | Buy |
|
|||||
|
2022
Q2 | $668K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $245K | Sell |
|
|||||
|
2021
Q2 | $688K | Buy |
|
|||||
|
2021
Q1 | $211K | Buy |
|
|||||
|
2020
Q4 | $263K | Sell |
|
|||||
|
2020
Q3 | $1.97M | Buy |
|
|||||
|
2020
Q2 | $952K | Sell |
|
|||||
|
2020
Q1 | $1.26M | Sell |
|
|||||
|
2019
Q4 | $2.8M | Sell |
|
|||||
|
2019
Q3 | $2.73M | Buy |
|
|||||
|
2019
Q2 | $2.26M | Sell |
|
|||||
|
2019
Q1 | $1.94M | Buy |
|
|||||
|
2018
Q4 | $1.31M | Sell |
|
|||||
|
2018
Q3 | $2.46M | Sell |
|
|||||
|
2018
Q2 | $1.49M | Sell |
|
|||||
|
2018
Q1 | $1.07M | Sell |
|
|||||
|
2017
Q4 | $1.15M | Buy |
|
|||||
|
2017
Q3 | $1.07M | Buy |
|
|||||
|
2017
Q2 | $871K | Sell |
|
|||||
|
2017
Q1 | $424K | Sell |
|
|||||
|
2016
Q4 | $514K | Buy |
|